- Total revenue increased by 9.27% QoQ to ₹209.77 crores, with EBITDA margin reaching 29.21%
Surat, October 18, 2024: Aether Industries Limited, India’s leading specialty chemical manufacturer, has announced its financial results for the second quarter ended on September 30, 2024, demonstrating strong performance and continued growth momentum. The company has also achieved improvements in its working capital cycle and cash flow management.
Financial Highlights:
| Particulars (Cr.) | Q2FY25 | Q1FY25 | QoQ |
| Revenue | 209.77 | 191.98 | 9.27% |
| EBITDA | 61.28 | 52.12 | 17.56% |
| EBITDA Margin (%) | 29.21% | 27.15 % | |
| PAT | 34.80 | 29.93 | 16.26% |
| PAT Margin (%) | 16.59 | 15.59% |
Q2 FY25 vs Q1 FY25 Highlights:
- Revenue from Sales stood at ₹198.80 crores in Q2 FY25, a 10.43% increase compared to Q1 FY25
- Total Revenue of ₹209.77 crores, reflecting a 9.27% growth quarter-on-quarter
- EBITDA for Q2 FY25 was ₹61.28 crores, up 17.56% from the previous quarter
- Profit After Tax (PAT) increased to ₹34.80 crores in Q2 FY25, registering a 16.26% rise QoQ.
Additionally, the company has successfully reduced its working capital cycle, paving a way to better ratios in near future and has registered a positive cash flow from operations for both the quarter and the six-month period under review, underscoring its commitment to efficient financial management and operational excellence.
H1 FY25 vs H1 FY24 Highlights:
- Total Revenue grew to ₹401.75 crores for H1 FY25, a 17.58% increase over H1 FY24
- EBITDA improved by 5.89% to ₹113.40 crores compared to the same period last year
- PAT for H1 FY25 was ₹64.73 crores
Rohan Desai, Promoter & Whole-time Director of Aether Industries, commented, said “Our financial results for this quarter reflect our strategic focus on growth and operational efficiency. The reduced working capital cycle and positive cash flow from operations are strong indicators of our ability to manage resources effectively. We have successfully managed to increase our EBITDA margin while maintaining robust revenue growth. This demonstrates our commitment to delivering value to our stakeholders and reinforces our position as a leader in the specialty chemicals sector. Looking ahead, we remain focused on expanding our market presence and driving sustainable growth.”
“We are excited to announce the commencement of our new 5MW Auto Tracker Solar Power Plant, which is expected to significantly reduce one of our major costs—electricity. By harnessing solar energy, we aim to enhance our EBITDA and PAT margins, improving overall profitability. The plant’s innovative auto-tracking system will maximize energy efficiency, leading to better tax savings through depreciation benefits, while also boosting cash flows. With the final phase of this project set to go live within a month, we will soon start generating additional revenue for the company.”, he added.
About Aether Industries Ltd (https://aether.co.in/) BSE: 543534; NSE: AETHER
Incorporated in 2013, Aether Industries Limited is a specialty chemical manufacturer in India focused on producing advanced intermediates and specialty chemicals involving complex and differentiated chemistry and technology core competencies. Our vision is to create a niche in the global chemical industry with a creative approach towards chemistry, technology and systems leading to sustainable growth. We began commercial operations in the last quarter of FY17 and stand to be one of the fastest growing specialty chemical firms in India. The company has an installed capacity of 6000 MT as on date and operates its state of the art and DCS automated manufacturing facilities in Surat, Gujarat. We are ISO 9001: 2015, ISO 14001:2015, ISO 45001:2018, ISMS 27001:2013 and Indian GMP certified.
The Promoters (Mr. Ashwin Desai, MD, Ms. Purnima Desai, WTD, Mr. Rohan Desai, WTD and Dr. Aman Desai, WTD) lead the Company from the front with their techno-commercial mix, where Mr. Ashwin Desai being Technical Expert and Ms. Purnima Desai being Commercial Expert in the older generation and Dr. Aman Desai being Technical Expert and Mr. Rohan Desai being Commercial Expert, adds tremendous value to the Company. Our Board of Directors led by our Promoters, being the Executive Directors of our Board. We are further enriched by our Board Members who are technically sound and have extensive experience in various fields like chemicals, pharmaceuticals, accountancy, finance, and project implementation, who add tremendous value and vision to our Company. We are further enriched with the 3 Senior Management Personnel (Dr. James Ringer, Mr. Ray Roach and Dr. Norbert Fluggen), who add technical expertise and bring in years of experience from their past engagements with various multinational giants like Dow, Altana, companies.
